Apoptosis loss and Bcl-2 expression: Key determinants of lymph node metastases in T1 breast cancer

Clinical Cancer Research

Volumn 2, Issue 11, 1996, Pages 1887-1894

  Sierra, Angels ^a   Castellsagué, Xavier ^a   Tórtola, Silvia ^a   Escobedo, Agustín ^b   Lloveras, Belen ^a   Peinado, Miguel A ^a   Moreno, Abelardo ^a   Fabra, Angels ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b HOSPITAL DURAN I REYNALS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; BREAST CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; AGED; APOPTOSIS; BREAST NEOPLASMS; CELL DIVISION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGED; MUTATION; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029829173     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Sierra, A., Lloveras, B., Castellsagué, X., Moreno, L., García-Ramirez, M., and Fabra, A. Bcl-2 expression is associated with lymph node metastasis in human ductal breast carcinoma. Int. J. Cancer, 60: 54-60, 1995.
2. Merritt, A. J., Potten, C. S., Watson, A J. M , Loh, D. Y., Nakayama, K., Nakayama, K., and Hickman, J. A. Differential expression of bcl-2 in intestinal epithelia. Correlation with attenuation of apoptosis in colonic crypts and the incidence of colonic neoplasia J. Cell Sci., 108: 2261-2271, 1995.
3. Bedi, A., Pasricha, P. J., Akhtar, A. J., Barber, J. P., Bedi, G. C., Giardiello, F. M., Zehnbauer, B. A., Hamilton, S. R., and Jones, R. J. Inhibition of apoptosis during development of colorectal cancer. Cancer Res., 55: 1811-1816, 1995.
4. Leek, R. D., Kaklamanis, L., Pezzella, F., Gatter, K. C., and Harris, A. L. bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer. Br. J. Cancer, 69: 135-139, 1994.
5. Silvestrini, R., Veneroni, S., Daidone, M G , Benini, E., Boracchi, P , Mezzetti, M., Di Fronzo, G , Rilke, F., and Veronesi, U. The Bcl-2 protein, a prognostic indicator strongly related to p53 protein in lymphnode-negative breast cancer patients. J. Natl. Cancer Inst., 86, 499-504, 1994.
6. Sinicrope, F. A., Ruan, S. B., Cleary, K. R., Stephens, L. C., Lee, J. J., and Levin, B. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res., 55: 237-241, 1995.
7. Strasser, A., Harris, A. W., Jacks, T., and Cory, S DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell, 79: 329-339, 1994.
8. Haldar, S., Negrini, M., Monne, M., Sabbioni, S., and Croce, C. M. Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res., 54: 2095-2097, 1994.
9. McDonnell, T. J. Cell division versus cell death: a functional model of multistep neoplasia. Mol Carcinog , 8; 209-213, 1993.
10. Hockenbery, D. M. bcl-2 in cancer, development and apoptosis. J. Cell Sci., 18: 51-55, 1994.
11. Gavrieli, Y., Sherman, Y., and Ben-Sasson, S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 119: 493-501, 1992.
12. Bartkova, J., Bartek, J., Vojtesek, B., Lukas, J., Rejthar, A., Kovarik, J., Millis, R. R., Lane, D. P., and Barnes, D. M. Immunochemical analysis of the p53 oncoprotein in matched primary and metastatic human tumours. Eur. J. Cancer, 29A: 881-886, 1993.
13. Cunningham, J. M., Ingle, J. N., Jung, S. H., Cha, S. S., Wold, L. E., Farr, G., Witzig, T. E., Krook, J. E , Wieand, H. S., and Kovach, J. S. p53 gene expression in node-positive breast cancer: relationship to DNA ploidy and prognosis. J. Natl. Cancer Inst., 86: 1871-1873, 1994.
14. Joensuu, H., Pylkkänen, L., and Toikkanen, S. Bcl-2 protein expression and long-term survival in breast cancer. Am. J. Pathol., 145: 1191-1198, 1994.
15. Ceccarelli, C., Santini, D., Chieco, P., Taffurelli, M., Marrano, D., and Mancini, A. M. Multiple expression patterns of biopathological markers in primary invasive breast carcinoma: a useful tool for elucidating its biological behaviour. Ann. Oncol., 6: 275-282, 1995.
16. Hollstein, M., Sidransky, D., and Volgelstein, B. p53 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
17. Orita, M., Iwahana, H., Kanazawa, H., Hayashy, K., and Sekiya, T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc. Natl. Acad. Sci. USA, 86: 2766-2770, 1989.
18. Sambrook, J., Fitsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, Ed. 2, p. 13.63. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory, 1989.
19. Dean, A. G., Dean, J. A., Coulombier, D., Brendel, K. A., Smith, D. C., Burton, A. H., Dicker, R C., Sullivan, K., Fagan, R. F., and Arner, T. G. Epi Info, Version 6. a word processing, database, and statistics program for epidemiology on microcomputers. Centers for Disease Control and Prevention, Atlanta, Georgia, U.S.A., 1994.
20. Breslow, N. E , and Day, N. E. Statistical Methods in Cancer Research. I. The Analysis of Case-Control Studies. IARC Scientific Publ. No. 32. Lyon, France. IARC, 1980
21. Baker, R. J., and Neider, J. A. The GLIM system, Release 3. Generalized linear interactive modelling Oxford, United Kingdom: Numerical Algorithms Group, 1978.
22. Doglioni, C., Dei Tos, A. P., Laurino, L., Chiarelli, C., Barbareschi, M., and Viale, G. The prevalence of Bcl-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status. Virchows Arch , 424: 47-51, 1994.
23. Nathan, B , Gusterson, B., Jadayel, D., O'Hare, M., Anbazhagan, R., Jayatilake, H., Ebbs, S., Micklem, K., Price, K., Gelber, R., Reed, R., Senn, H-J., Goldhirsch, A., and Dyer, M. J S. Expression of Bcl-2 in primary breast cancer and its correlation with tumour phenotype. Ann. Oncol., 5: 409-414, 1994.
24. Lipponen, P., Pietiläinen, T., Kosma, V-M., Aaltomaa, S., Eskelinen, M., and Syrjänen, K. Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis. J. Pathol., 177: 49-55, 1995.
25. Hellemans, P , van Dam, P. A., Weyler, J., van Oosterom, A. T., Buytaert, P., and Van Marck, E. Prognostic value of bcl-2 expression in invasive breast cancer. Br. J. Cancer, 72: 354-360, 1995.
26. Ravdin, P. M., De Laurentiis, M., Vendely, T., and Clark, G. M. Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators. J. Natl. Cancer Inst., 86: 1771-1774, 1994
27. Chiou, S., Rao, L., and White, E. Bcl-2 blocks p53-dependent apoprosis. Mol. Cell. Biol., 14: 2556-2563, 1994
28. Wang, Y., Szekely, L., Okan, I., Klein, G., and Wiman, K. G. Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line. Oncogene, 8: 3427-3431, 1993.
29. Marin, M. C., Hsu, B., Meyn, R. E., Donehower, L. A., El-Naggar, A. K., and McDonnell, T. J Evidence that p53 and bcl-2 are regulators of a common cell death pathway important for in vivo lymphomagenesis. Oncogene, 9: 3107-3112, 1994.
30. Gorczyca, W., Markiewski, M., Kram, A., Tuziak, T., and Damagala, W. Immunohistochemical analysis of bcl-2 and p53 expression in breast carcinomas: their correlation with Ki-67 growth fraction. Virchows Arch., 420: 229-233, 1995.
31. Hurlimann, J., Larrinaga, B., and Vala, D. L. M. bcl-2 protein in invasive ductal breast carcinomas. Virchows Arch., 426: 163-168, 1995.
32. Jackson, P., Ridgway, P., Rayner, J., Noble, J., and Braithwaite, A. Transcriptional regulation of the PCNA promoter by p53. Biochem. Biophys. Res. Commun , 203: 133-140, 1994.
33. Symonds, H., Krall, L., Remington, L., Saenz-Robles, M., Lowe, S., Jacks, T , and Van Dyke, T. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell, 78: 703-711, 1994.
34. Marchetti, A., Buttitta, F., Pellegrini, S., Campani, D., Diella, F., Cecchetti, D., Callahan, R., and Bistocchi, M. p53 mutations and histological type of invasive breast carcinoma Cancer Res., 53: 4665-4669, 1993.
35. Lipponen, P., Ji, H., Aaltomaa, S., Syrjänen, S., and Syrjänen, K. p53 protein expression in breast cancer as related to histopathological characteristics and prognosis. Int. J. Cancer, 55, 51-56, 1993.
36. Jacquemier, J., Molès, J. P., Penault-Llorca, F., Adélaide, J., Torrente, M., Viens, P., Birnbaum, D , and Theillet, C. p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: comparison of staining and PCR-SSCP results. Br. J. Cancer, 69: 846-852, 1994.
37. Korsmeyer, S. J. Regulators of cell death. Trends in Genet., 11: 101-105, 1995.
38. Cory, S. Regulation of lymphocyte survival by the bcl-2 gene family. Annu. Rev. Immunol. 13: 513-543, 1995.
39. L and Bcl-2, displaces Bax and promotes cell death. Cell, 80: 285-291, 1995.
40. Oltvai, Z. N., Milliman, C. L., and Korsmeyer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death. Cell, 74: 609-619, 1993.
41. Miyashita, T., Harigai, M., Hanada, M., and Reed, J. C. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res., 54: 3131-3135, 1994.
42. Oltvai, Z. N., and Korsmeyer, S. J. Checkpoints of dueling dimers foil death wishes. Cell, 79: 189-192, 1994.
43. Hoffman, B., and Liebermann, D. A. Molecular controls of apoptosis: differentiation/growth arrest primary response genes, proto-oncogenes, and tumor suppressor genes as positive and negative modulators. Oncogene, 9: 1807-1812, 1994.
44. Bargou, R. C., Daniel, P. T., Mapara, M Y., Bommert, K., Wagener, C., Kallinich, B., Royer, H. D., and Dorken, B. Expression of the bcl-2 gene family in normal and malignant breast tissue, low bax-α expression in tumor cells correlates with resistance towards apoptosis Int. J. Cancer, 60: 854-859, 1995.